TriSalus Life Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TLSI and other ETFs, options, and stocks.

About TLSI

TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020, and is headquartered in Westminster, CO.

CEO

Mary T. Szela

CEOMary T. Szela

Employees

110

Employees110

Headquarters

Westminster, Colorado

HeadquartersWestminster, Colorado

Founded

2020

Founded2020

Employees

110

Employees110

TLSI Key Statistics

Market cap

202.44M

Market cap202.44M

Price-Earnings ratio

-4.80

Price-Earnings ratio-4.80

Dividend yield

—

Dividend yield—

Average volume

36.91K

Average volume36.91K

High today

—

High today—

Low today

—

Low today—

Open price

$5.10

Open price$5.10

Volume

0.00

Volume0.00

52 Week high

$10.10

52 Week high$10.10

52 Week low

$3.50

52 Week low$3.50

Analyst ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own TLSI. This list is generated using Robinhood data, and it’s not a recommendation.